Literature DB >> 31012303

Pyrrole-Hemoglobin Adducts, a More Feasible Potential Biomarker of Pyrrolizidine Alkaloid Exposure.

Jiang Ma1,2, Jianqing Ruan1,2, Xinmeng Chen1,2, Dongping Li3, Sheng Yao2,4, Peter P Fu5, Yang Ye2,4, Hong Gao3, Jiyao Wang3, Ge Lin1,2.   

Abstract

Pyrrolizidine alkaloids (PAs) are naturally occurring phytotoxins widely distributed in about 3% of flowering plants. The formation of PA-derived pyrrole-protein adducts is considered as a primary trigger initiating PA-induced hepatotoxicity. The present study aims to (i) further validate our previous established derivatization method using acidified ethanolic AgNO3 for the analysis of pyrrole-protein adducts and (ii) apply this method to characterize the binding tendency, dose-response, and elimination kinetics of pyrrole-protein adducts in blood samples. Two pyrrole-amino acid conjugates, (±)-6,7-dihydro-7-hydroxy-1-hydroxymethyl-5 H-pyrrolizine (DHP)-cysteine (7-cysteine-DHP) and 9-histidine-DHP, were synthesized and used to demonstrate that acidified ethanolic AgNO3 derivatization can cleave both S-linkage and N-linkage of pyrrole-protein adducts. Subsequently, using precolumn AgNO3 derivatization followed by ultra-high-pressure liquid chromatography/mass spectrometry analysis, we quantified pyrrole-protein adducts in monocrotaline-treated rat blood protein fractions, including hemoglobin (Hb), plasma, albumin, and plasma residual protein fractions, and found that the amount of pyrrole-Hb adducts was significantly higher than that in all plasma fractions. Moreover, elimination half-life of pyrrole-Hb adducts was also significantly longer than pyrrole-protein adducts in plasma fractions (12.08 vs 2.54-2.93 days). In addition, we also tested blood samples obtained from five PA-induced liver injury patients and found that the amount of pyrrole-protein adducts in blood cells was also remarkably higher than that in plasma. In conclusion, our findings for the first time confirmed that the AgNO3 derivatization method could be used to measure both S- and N-linked pyrrole-protein adducts and also suggested that pyrrole-Hb adducts with remarkably higher level and longer life span could be a better biomarker of PA exposure.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31012303     DOI: 10.1021/acs.chemrestox.8b00369

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  10 in total

1.  Fasting augments pyrrolizidine alkaloid-induced hepatotoxicity.

Authors:  Jiang Ma; Chunyuan Zhang; Yisheng He; Xinmeng Chen; Ge Lin
Journal:  Arch Toxicol       Date:  2021-11-18       Impact factor: 5.153

2.  Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human.

Authors:  Lin Zhu; Chunyuan Zhang; Wei Zhang; Qingsu Xia; Jiang Ma; Xin He; Yisheng He; Peter P Fu; Wei Jia; Yuzheng Zhuge; Ge Lin
Journal:  Arch Toxicol       Date:  2021-08-14       Impact factor: 6.168

3.  Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans.

Authors:  Jiang Ma; Wei Zhang; Yisheng He; Lin Zhu; Chunyuan Zhang; Jia Liu; Yang Ye; Yuzheng Zhuge; Ge Lin
Journal:  Arch Toxicol       Date:  2020-11-18       Impact factor: 5.153

4.  Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites.

Authors:  Yisheng He; Wei Lian; Liang Ding; Xiaoyu Fan; Jiang Ma; Qing-Yu Zhang; Xinxin Ding; Ge Lin
Journal:  Arch Toxicol       Date:  2020-10-08       Impact factor: 5.153

Review 5.  Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids.

Authors:  Yisheng He; Lin Zhu; Jiang Ma; Ge Lin
Journal:  Arch Toxicol       Date:  2021-05-18       Impact factor: 5.153

6.  The key role of gut-liver axis in pyrrolizidine alkaloid-induced hepatotoxicity and enterotoxicity.

Authors:  Yisheng He; Jiang Ma; Xiaoyu Fan; Liang Ding; Xinxin Ding; Qing-Yu Zhang; Ge Lin
Journal:  Acta Pharm Sin B       Date:  2021-07-21       Impact factor: 11.413

Review 7.  Quo vadis blood protein adductomics?

Authors:  Gabriele Sabbioni; Billy W Day
Journal:  Arch Toxicol       Date:  2021-11-13       Impact factor: 5.153

8.  Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.

Authors:  Jiang Ma; Mi Li; Na Li; Wood Yee Chan; Ge Lin
Journal:  Toxins (Basel)       Date:  2021-10-13       Impact factor: 4.546

9.  Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation.

Authors:  Zhangting Wang; Jiang Ma; Sheng Yao; Yisheng He; Kai-Kei Miu; Qingsu Xia; Peter P Fu; Yang Ye; Ge Lin
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

Review 10.  Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China.

Authors:  Lin Zhu; Chun-Yuan Zhang; Dong-Ping Li; Hu-Biao Chen; Jiang Ma; Hong Gao; Yang Ye; Ji-Yao Wang; Peter P Fu; Ge Lin
Journal:  Acta Pharmacol Sin       Date:  2020-11-05       Impact factor: 7.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.